Capital Markets

Cooley's Capital Markets lawyers advise issuers, investment banks and investors in equity and debt transactions that raise capital through the public and private capital markets. Since 2009, we have been involved nearly 300 public offerings including some of the nation's most notable securities transactions.

We are one of the leading law firms advising companies in their securities transactions. According to IPO Vital Signs, Cooley was ranked the most active law firm representing either the issuers or underwriters in IPOs in the life sciences and technology sectors in 2013. As one of the most active law firms in this area, particularly in those sectors, we have deep industry-specific expertise as corporate counsel to high-growth companies that allows us to help our clients navigate the many challenges that arise during a company's lifecycle, including facilitating their access to the capital markets.

We also have significant experience representing the leading investment and commercial banks, placement agents, institutional investors, and venture, private equity and other private investment funds in a broad range of finance and banking transactions in the leading financial centers and emerging markets around the globe. We were recently recognized in American Lawyer's Corporate Scorecard as on of the top five most active law firms advising underwriters on U.S. and global IPOs.

Our Capital Markets lawyers work closely with our other practice groups such as compensation and benefits, regulatory, litigation, tax, mergers and acquisitions, intellectual property, licensing/partnering and antitrust and trade regulation to adeptly navigate the most complex and sensitive issues that arise in the context of capital markets transactions.

Transaction Types

Equity
  • Public Equity Offerings
    • Initial Public Offerings
    • Follow-on and Secondary Public Offerings
  • Shelf Registrations
  • Rule 144A/Regulation S Offerings
  • PIPE Transactions
  • Other Private Placements
    Debt/Preferred
    • Convertible Debt
    • Preferred Stock
    • High Yield Debt
    • Investment Grade Debt
    • Derivative Products
    • Mezzanine Capital
    • Royalty-backed and Other Structured
    • Debt Securities

    Recent Rankings and Accolades

    • #1 Law Firm for issuer side IPOs across all industries in 1H 2014 (IPO Vital Signs)
    • #1 Law Firm for U.S. incorporated technology and life sciences IPOs in 1H 2014 (IPO Vital Signs)
    • 45% Market Share for venture-backed IPOs across all industries in 1H 2014 (Thomson Reuters/NVCA)
    • #1 Law Firm representing issuers and underwriters in IPOs in the life sciences and technology sectors in 2013 (IPO Vital Signs)
    • #1 Law Firm advising issuers for U.S. venture-backed IPOs in 2013 (Pitchbook and IPO Vital Signs)
    • #1 Law Firm advising issuers in Life Science IPOs from 2000 to the present (VentureSource)

    Related Practices

    Cooley Insights: IPOs

    There are many considerations to evaluate in preparing for an IPO.Check out our tip sheet for the top 25 issues to review. Read more.

    PubCo @ Cooley Blog

    A resource on newsworthy regulatory developments, corporate governance matters, SEC reporting and compliance topics, and general trends pertinent to public companies. Read here.


    ©2003-2014 Cooley LLP. All rights reserved.
    COOLEY® and the COOLEY LLP® logo are registered U.S. service marks of Cooley LLP.
    Cooley was founded in 1920 – for our story, visit our history page.